Michel R. Nasr

Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: utility of HBME1 combined with CK19 immunostaining

Michel R. Nasr, Sanjay Mukhopadhyay, Shengle Zhang et al. · Modern Pathology · 2006 · 123 citations

Medicine, Oncology, Pathology +14

Comparison of pHH3, Ki-67, and Survivin Immunoreactivity in Benign and Malignant Melanocytic Lesions

Michel R. Nasr, Ola El‐Zammar · American Journal of Dermatopathology · 2008 · 121 citations

Medicine, Dermatology, Pathology +17

Loss of CD20 expression in relapsed lymphomas after rituximab therapy

Joud H. Haidar, Ali Shamseddine, Ziad Salem et al. · European Journal Of Haematology · 2003 · 58 citations · Full text

Medicine, Immunology, Oncology +16

Frequency of <i>MYD88</i> and <i>CD79B</i> mutations, and <i>MGMT</i> methylation in primary central nervous system diffuse large <scp>B</scp>‐cell lymphoma

Mei Lian Zheng, Anamarija M. Perry, Philip J. Bierman et al. · Neuropathology · 2017 · 47 citations

Medicine, Molecular Biology, Oncology +17

A Case Report on the Role of Plasma Exchange in the Management of a Massive Amlodipine Besylate Intoxication

Christian Ezidiegwu, Zhanna Spektor, Michel R. Nasr et al. · Therapeutic Apheresis and Dialysis · 2008 · 42 citations

Medicine, Cardiology, Pharmacology +11